Recommendations for medical care of oncological patients during the COVID-19 epidemic: experiences from China.
作者信息
Zhao Hong, Du Shunda, Cai Jianqiang, Mao Yilei
机构信息
Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Shuaifuyuan, Wangfujing, Dong-Cheng, Beijing, 100730, China.
出版信息
Updates Surg. 2020 Jun;72(2):235-236. doi: 10.1007/s13304-020-00791-w. Epub 2020 May 12.
Abstract
摘要
相似文献
1
Recommendations for medical care of oncological patients during the COVID-19 epidemic: experiences from China.2019冠状病毒病疫情期间肿瘤患者的医疗照护建议：来自中国的经验
Updates Surg. 2020 Jun;72(2):235-236. doi: 10.1007/s13304-020-00791-w. Epub 2020 May 12.
2
100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program.百日孤独：透过“启动计划”15位年轻病毒学家的视角看新冠疫情之春
Virus Res. 2020 Oct 2;287:198093. doi: 10.1016/j.virusres.2020.198093. Epub 2020 Jul 28.
3
Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China.洞察 COVID-19 疫情对中国结核病负担的影响。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02710-2020. Print 2020 Sep.
4
[SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals].[严重急性呼吸综合征冠状病毒2型/冠状病毒病19感染与实体癌：卫生专业人员建议综述]
Bull Cancer. 2020 Apr;107(4):400-402. doi: 10.1016/j.bulcan.2020.03.001. Epub 2020 Mar 27.
5
[Recommendations for delayed immunization with non-National Immunization Program vaccines based on safety and efficacy analyses during the epidemic of COVID-19 in China].[基于中国新冠疫情期间安全性和有效性分析对非国家免疫规划疫苗延迟接种的建议]
Zhonghua Er Ke Za Zhi. 2020 Apr 2;58(4):263-268. doi: 10.3760/cma.j.cn112140-20200217-00097.
6
What to do next to control the 2019-nCoV epidemic?接下来要采取什么措施来控制2019新型冠状病毒疫情？
Lancet. 2020 Feb 8;395(10222):391-393. doi: 10.1016/S0140-6736(20)30300-7.
7
Life and Death, Hope and Despair in the Era of Coronavirus Disease 2019.2019年冠状病毒病时代的生与死、希望与绝望
JAMA Cardiol. 2020 Sep 1;5(9):985. doi: 10.1001/jamacardio.2020.2420.
8
The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province.远程医疗在中国新冠疫情期间的作用——来自山东省的经验
Crit Care. 2020 Apr 28;24(1):178. doi: 10.1186/s13054-020-02884-9.
9
China empowers Internet hospital to fight against COVID-19.中国赋予互联网医院抗击新冠疫情的能力。
J Infect. 2020 Jul;81(1):e67-e68. doi: 10.1016/j.jinf.2020.03.061. Epub 2020 Apr 3.
10
Covid-19: Most trainees have faced disruption to their training, GMC survey shows.英国医学总会调查显示：新冠疫情期间，多数实习医生培训受干扰。
BMJ. 2020 Oct 21;371:m4093. doi: 10.1136/bmj.m4093.
引用本文的文献
1
Impact and control of the COVID pandemic in an elite sports club: Real Madrid.新冠疫情对精英体育俱乐部的影响及控制：皇马。
Rev Esp Quimioter. 2023 Feb;36(1):59-64. doi: 10.37201/req/072.2022. Epub 2022 Nov 7.
2
The Effects of the COVID-19 Pandemic in Oncology Patient Management.COVID-19 大流行对肿瘤患者管理的影响。
Int J Environ Res Public Health. 2022 Jul 25;19(15):9041. doi: 10.3390/ijerph19159041.
3
Impact of waiting time on hepatocellular carcinoma progression in patients undergoing curative tumour ablation.等待时间对接受根治性肿瘤消融治疗的肝细胞癌患者病情进展的影响。
Quant Imaging Med Surg. 2022 Feb;12(2):1499-1504. doi: 10.21037/qims-20-1411.
本文引用的文献
1
Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.在中国新冠疫情传播期间照顾癌症患者的积极有效措施
JAMA Oncol. 2020 May 1;6(5):631-632. doi: 10.1001/jamaoncol.2020.1198.
2
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.乐伐替尼与索拉非尼用于不可切除肝细胞癌患者一线治疗的比较：一项随机、III 期非劣效性试验。
Lancet. 2018 Mar 24;391(10126):1163-1173. doi: 10.1016/S0140-6736(18)30207-1.
3
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.在等待索拉非尼安全性数据的同时，对肝癌患者在肝移植前使用索拉非尼的成本效益分析。
Hepatology. 2010 Jan;51(1):165-73. doi: 10.1002/hep.23260.
Zotero 插件